Review: Dendritic Cells and Cancer: Progress Toward a New Cellular Therapy
- 1 December 1997
- journal article
- review article
- Published by Mary Ann Liebert Inc in Journal of Hematotherapy
- Vol. 6 (6), 523-533
- https://doi.org/10.1089/scd.1.1997.6.523
Abstract
No abstract availableThis publication has 86 references indexed in Scilit:
- Vaccination of melanoma patients with peptide-pulsed dendritic cellsMelanoma Research, 1997
- CAPTURE AND PROCESSING OF EXOGENOUS ANTIGENS FOR PRESENTATION ON MHC MOLECULESAnnual Review of Immunology, 1997
- In Vitro Generation of Human Cytotoxic T Lymphocytes Specific for Peptides Derived From Prostate-Specific AntigenJNCI Journal of the National Cancer Institute, 1997
- Adoptive immunotherapy post bone-marrow transplantationBlood Reviews, 1996
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Cellular Mucins: Targets for ImmunotherapyCritical Reviews in Immunology, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Interstitial Dendritic CellsInternational Reviews of Immunology, 1990